Changes

Jump to navigation Jump to search

Patholines:Editorial guidelines

254 bytes added, 09:31, 2 May 2021
::This section may contain a subsection titled '''Most common direct requests''', which can include diagnoses, such as [[Skin]] mentioning [[Melanoma of the skin]].
*'''Gross processing'''
:*'''Triage''', when the specimen type often comes fresh. This describes procedures done until the specimen is put in formalin for later grossing.
:*'''Basic gross examination''', basic evaluation assuming that no pathology is present, leaving procedures for specific presentations or diseases to be described in their individual articles instead.
:*'''Tissue selection''', generally including necessary slices or other samples that are sent for further processing, in order to make a basic screening. This section may also include guidelines for additional cuts and trimming that are often useful, and can then be titled '''Tissue selection and trimming'''.
:*'''Gross report''', as in Presentation articles
*'''Microscopic/Histopathologic evaluation''', preferably including:
:*'''Characteristics/Microscopic characteristics''' such as diagnostic criteria. For features not seen in the vast majority of cases with the diagnosis of interest, note whether they are specific, or which conditions they help rule out (rather than just mentioning that the condition "sometimes displays" the feature).
::*'''Variants''', in case the condition has notable different appearances.
:::Generally describe what can be seen rather than processes (such as preferring "an abundance of" rather than "proliferation of").
:*'''Differential diagnoses''', including how to distinguish it from at least the most common and/or important differential diagnoses. There should be no plain list of differential diagnoses (see [[#No plain lists of causes|the section ''No plain lists of causes'']] below). More detailed descriptions of overlapping cases can be described in a template that appears in the main articles of both, such as {{tl|Overlap of squamous-cell and basal-cell carcinoma}}, or as a separate article, such as [[Follicular lymphoma versus reactive follicular hyperplasia]].
::*Any mention of '''immunohistochemistry''' staining should include the conditions that stain helps to indicate. ''Example: [[Lobular carcinoma in situ#Microscopic evaluation|Lobular carcinoma in situ]]''

Navigation menu